Skip to main content

Table 2 PVF values at pre-treatment (day0), day14 and day28 for each group, and the change from baseline

From: The effectiveness of marine based fatty acid compound (PCSO-524) and firocoxib in the treatment of canine osteoarthritis

 

Time

Firocoxib

PCSO-524

Combination

P-value*

PVF (%BW)

Day 0 (PVF)

64.79 ± 5.98 a

62.01 ± 6.85 a

59.97 ± 9.38 a

0.069

Day 14 (PVF)

Mean change±SD

67.82 ± 6.70 b

3.03 ± 4.67

63.82 ± 6.15 b

1.82 ± 3.22

62.71 ± 9.15 b

2.74 ± 4.41

 

Day 28 (PVF)

Mean change±SD

68.05 ± 6.29 b

3.25 ± 4.13

64.01 ± 6.52 b

2.01 ± 3.86

64.08 ± 9.99 b

4.11 ± 4.69

 
  1. SD standard deviation
  2. a, bp-value < 0.05 from Tukey’s Studentized Range within each treatment
  3. *p-value from repeated measurement analysis for 3 treatments